Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Corticotropin-releasing hormone (CRH) is a potent mediator of endocrine, autonomic, behavioural and immune responses to stress, and has been implicated in the stress-like and other aversive consequences of drug abuse, such as withdrawal from alcohol. Two CRH receptors, Crhr1 and Crhr2, have been identified in the mouse. Crhr1 is highly expressed in the anterior pituitary, neocortex, hippocampus, amygdala and cerebellum, and activation of this receptor stimulates adenylate cyclase. Here we show that in mice lacking Crhr1, the medulla of the adrenal gland is atrophied and stress-induced release of adrenocorticotropic hormone (ACTH) and corticosterone is reduced. The homozygous mutants exhibit increased exploratory activity and reduced anxiety-related behaviour under both basal conditions and following alcohol withdrawal. Our results demonstrate a key role of the Crhr1 receptor in mediating the stress response and anxiety-related behaviour.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, plasma corticosterone levels in Crhr1 KO mice were significantly less than those of WT mice after forced-swim stress (15).”
From Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation (2000) · cites this paper as [15]
In the citing paper
“CRF 1 overexpression results in an anxiogenic-and depressive-like profile in rodents and humans [342][343][344][345][346].”
From Anxiety, depression, and the microbiome: A role for gut peptides (2018) · cites this paper as [343]
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“CRH functions as the prime mediator in stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation by triggering the immediate release of ACTH from the anterior pituitar”
BackgroundVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142 · cited 1×
“CRH functions as the prime mediator in stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation by triggering the immediate release of ACTH from the anterior pituitar”
BackgroundCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946
Chalmers, D., Lovenberg, T., & De Souza, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06340.1995 · Cited by 919
Gene Targeting: A Practical Approach
Hirst, M. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.821-a · Cited by 585
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Swanson, L. W., & Simmons, D. M. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902850402 · Cited by 478
Stenzel-Poore, M., Heinrichs, S., Rivest, S., Koob, G., & Vale, W. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02579.1994 · Cited by 468
Cited by
Items 401–500 of 1,000
Major depression: emerging therapeutics
Sen, S., & Sanacora, G. (2008) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20043 · Cited by 47
Stevens, S. L., Shaw, T., Dykhuizen, E. C., Lessov, N. S., Hill, J. K., Wurst, W., & Stenzel‐Poore, M. P. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000086957.72078.d4 · Cited by 55
“CRH-R1 deficient mice (Crhr1-/-) were obtained from Dr. Wolfgang Wurst, Max Planck Institute of Psychiatry, Munich, Germany (Timpl et al., 1998).”
MethodSelf-citationRomanowski, C. P., Fenzl, T., Flachskamm, C., Wurst, W., Holsboer, F., Deussing, J. M., & Kimura, M. (2010) · Sleep · doi:10.1093/sleep/33.4.427 · Cited by 47
Self-citationCharacterizing the neurotranscriptomic states in alternative stress coping styles
Wong, R. Y., Lamm, M. S., & Godwin, J. (2015) · BMC Genomics · doi:10.1186/s12864-015-1626-x · Cited by 54
“Our results are consistent with previous studies documenting the involvement of GABAergic [42-44], nonapeptides [45,46], and glucocorticoid [47-51] neurotransmitter and molecular pathways in physiological and behavioral responses to stress.”
Corticotropin-releasing factor type-1 receptor antagonists: The next class of antidepressants?
Nielsen, D. M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.06.003 · Cited by 54
Parham, K. L., Zervou, S., Karteris, E., Catalano, R. D., Old, R. W., & Hillhouse, E. W. (2004) · Endocrinology · doi:10.1210/en.2004-0194 · Cited by 49
Lee, S., Schmidt, E. D. L., Tilders, F. J. H., & RIVIER, C. L. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02132.x · Cited by 54
Pournajafi-Nazarloo, H., Partoo, L., Yee, J., Stevenson, J., Sanzenbacher, L., Kenkel, W., Mohsenpour, S. R., Hashimoto, K., & Carter, C. S. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.10.015 · Cited by 53
“Mice deficient in CRH-R1 display a decreased anxiety-like behavior and have an impaired stress response (Smith et al., 1998; Timpl et al., 1998); in contrast CRH-R2-mutant mice display an increased anxietylike behavior and are hypersensitive to stress (Bale et al., 2000).”
BackgroundCRHR1 promoter hypomethylation: An epigenetic readout of panic disorder?
Schartner, C., Ziegler, C., Schiele, M. A., Kollert, L., Weber, H., Zwanzger, P., Arolt, V., Pauli, P., Deckert, J., Reif, A., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.01.005 · Cited by 53
Koutmani, Y., Politis, P. K., Elkouris, M., Agrogiannis, G. D., Kemerli, M., Patsouris, E., Remboutsika, E., & Karalis, K. P. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.198 · Cited by 53
Tanaka, M., & Telegdy, G. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.08.009 · Cited by 53
Differential involvement of amygdaloid CRH system(s) in the salience and valence of the stimuli
Merali, Z., Michaud, D. S., McIntosh, J. F., Kent, P., & Anisman, H. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.014 · Cited by 53
Weathington, J. M., & Cooke, B. M. (2012) · Endocrinology · doi:10.1210/en.2012-1815 · Cited by 45
Riedel, W., SCHLAPP, U., LECK, S., Netter, P., & NEECK, G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04251.x · Cited by 53
Lancel, M., Müller-Preuss, P., Wigger, A., Landgraf, R., & Holsboer, F. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00009-2 · Cited by 53
Self-citationGilmor, M. L., Skelton, K. H., Nemeroff, C. B., & Owens, M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045419 · Cited by 53
Castañeda-Cortés, D. C., Padilla, L. F. A., Langlois, V. S., Somoza, G. M., & Fernandino, J. I. (2019) · Development · doi:10.1242/dev.172866 · Cited by 52
Anorexia in space and possible etiologies
Silva, M. S. D., Zimmerman, P. M., Meguid, M. M., Nandi, J., Ohinata, K., Xu, Y., Chen, C., Tada, T., & Inui, A. (2002) · Nutrition · doi:10.1016/s0899-9007(02)00915-2 · Cited by 52
Richard, S., Martínez‐Garciá, F., Lanuza, E., & Davies, D. C. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.11023 · Cited by 52
“Transgenic mice that over-express CRF show increased anxiety (Stenzel-Poore et al., 1994; Arborelius et al., 1999), whereas transgenic mice lacking CRF1 receptors show reduced emotionality and anxiety-like behavior (Timpl et al., 1998; Contarino et al., 1999).”
BackgroundTodorovic, C., Jahn, O., Tezval, H., Hippel, C., & Spiess, J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.014 · Cited by 51
Model systems in drug discovery: chemical genetics meets genomics
Carroll, P. M., Dougherty, B. A., Ross‐Macdonald, P., Browman, K., & Fitzgerald, K. J. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00059-7 · Cited by 51
CRF1 and CRF2 Receptors are Required for Potentiated Startle to Contextual but not Discrete Cues
Risbrough, V. B., Geyer, M. A., Hauger, R. L., Coste, S., Stenzel-Poore, M., Wurst, W., & Holsboer, F. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.205 · Cited by 49
“Separate naive cohorts of 2- to 3-month-old male and female CRF1 (Timpl et al, 1998) or CRF2 (Coste et al, 2000) WT and knockout (KO) mice bred in-house by heterozygous mating (backcrossed to C57BL/6J mice for more than 12 generations) were used for each experiment.”
MethodSelf-citationJee, C., Lee, J., Lim, J. P., Parry, D., Messing, R. O., & McIntire, S. L. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00829.x · Cited by 48
“We found that SEB-3 mediates responses to stress in C. elegans like the CRF1 receptor which mediates responses to stress in mammals (Grammatopoulos et al. 1999; Smith et al. 1998; Timpl et al. 1998).”
BackgroundAmygdala protein kinase C epsilon regulates corticotropin‐releasing factor and anxiety‐like behavior
Lesscher, H. M. B., McMahon, T., Lasek, A. W., Chou, W. ‐., Connolly, J., Kharazia, V., & Messing, R. O. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00356.x · Cited by 47
“…rats and mice, intracerebral infusion of CRF (Campbell et al. 2004; Nishikawa et al. 2004) and transgenic overexpression of CRF (Stenzel-Poore et al. 1994) increase anxiety-like behavior, whereas CRF1 receptordeficient mice show reduced anxiety-like behavior (Smith et al. 1998; Timpl et al. 1998).”
BackgroundNeuropeptides in Anxiety Modulation
Landgraf, R. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_12 · Cited by 48
Normal Physiology of ACTH and GH Release in the Hypothalamus and Anterior Pituitary in Man
Lim, C. T., & Khoo, B. C. E. (2014) · Cited by 48
Tan, J., Duan, T., Zhou, Q., Ding, Z., Jing, L., Cao, J., Wang, L., Mao, R., & Xu, L. (2014) · Addiction Biology · doi:10.1111/adb.12158 · Cited by 48
“Because anxiety-like behavior is an indicator for stress responses (Ma et al. 2007), hypofunction of the stress system will reduce anxiety (Smith et al. 1998; Timpl et al. 1998).”
BackgroundDisruption of the CRF2 Receptor Pathway Decreases the Somatic Expression of Opiate Withdrawal
Papaleo, F., Ghozland, S. G., Ingallinesi, M., Roberts, A. J., Koob, G. F., & Contarino, A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.8 · Cited by 48
Bangasser, D. A., & Kawasumi, Y. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.04.003 · Cited by 43
“Specifically, CRF1 receptor activation initiates the HPA axis response and leads to anxiogenic behavior (Bale and Vale, 2004; Contarino et al., 1999; Heinrichs et al., 1997; Smith et al., 1998; Takahashi, 2001; Timpl et al., 1998).”
BackgroundKiefer, F., Jahn, H., Köester, A., Montkowski, A., Reinscheid, R. K., & Wiedemann, K. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01486-5 · Cited by 47
Cooper, M. A., & Huhman, K. L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0849-1 · Cited by 47
“Data from pharmacological and receptor knockout studies indicate that activation of CRF-R1 increases a variety of stress-related behaviors (Heinrichs et al. 1997; Timpl et al. 1998; Contarino et al. 1999; Griebel et al. 2002).”
BackgroundTanaka, Y., Makino, S., Noguchi, T., Tamura, K., Kaneda, T., & Hashimoto, K. (2003) · Neuroendocrinology · doi:10.1159/000071700 · Cited by 44
Physiological Roles of Corticotropin-Releasing Hormone Receptor Type 2.
Hashimoto, K., Makino, S., Asaba, K., & Nishiyama, M. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.1 · Cited by 47
Dissecting the components of the central response to stress
Mayer, E. A., & Fanselow, M. S. (2003) · Nature Neuroscience · doi:10.1038/nn1003-1011 · Cited by 47
Dezsi, G., Ozturk, E., Salzberg, M. R., Morris, M., O'Brien, T. J., & Jones, N. C. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.005 · Cited by 46
Lack of Lithium-Like Behavioral and Molecular Effects in IMPA2 Knockout Mice
Cryns, K., Shamir, A., Shapiro, J., Daneels, G., Goris, I., Craenendonck, H. V., Straetemans, R., Belmaker, R. H., Agam, G., Moechars, D., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301154 · Cited by 46
Self-citationSchmidt, M. V., Oitzl, M. S., Müller, M. B., Ohl, F., Wurst, W., Holsboer, F., Levine, S., & de Kloet, E. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00097-6 · Cited by 46
Self-citationCline, M. A., Kuo, A. Y., Smith, M. L., Nandar, W., Prall, B. C., Siegel, P. B., & Denbow, D. M. (2008) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2008.09.008 · Cited by 46
Targeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior
Contarino, A., & Gold, L. H. (2002) · Neuropeptides · doi:10.1054/npep.2002.0899 · Cited by 46
Effects of the CRF1 antagonist SSR125543A on aggressive behaviors in hamsters
Farrokhi, C. B., Blanchard, D. C., Griebel, G., Yang, M., Gonzales, C. J., Markham, C. M., & Blanchard, R. J. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.12.023 · Cited by 46
“…behaviors in tests such as the open-field, light–dark box, defensive-withdrawal, and elevated plus maze (Contarino et al., 1999; Smith et al., 1998; Timpl et al., 1998); and from work using CRF1 receptor antagonists, again tending to show anxiolytic-like effects in the elevated plus maze (Griebel…”
BackgroundMethodIsogawa, K., Akiyoshi, J., Hikichi, T., Yamamoto, Y., Tsutsumi, T., & Nagayama, H. (2000) · Neuropeptides · doi:10.1054/npep.2000.0806 · Cited by 46
Kiang, J. G., & Ledney, G. D. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/821541 · Cited by 45
“Instead, at day 7, the corticosterone concentration was below but returned to baseline at day 11 (Figure 2(b)).”
Cooper, M. A., & Huhman, K. L. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.4.1042 · Cited by 42
Miguel, T. T., & Nunes‐de‐Souza, R. L. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.06.004 · Cited by 45
“Taken together, the present results suggest that the antianxiety effect following deletion of CRF1 receptor gene in mice observed elsewhere (Contarino et al., 1999; Smith et al., 1998; Timpl et al., 1998) might be at least in part due to a dysfunction of PAG CRF1 receptor activity.”
Villafuerte, S. M., Del‐Favero, J., Adolfsson, R., Souery, D., Massat, I., Mendlewicz, J., Van Broeckhoven, C., & Claes, S. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10179 · Cited by 40
Molecular Pathways of Anxiety Revealed by Knockout Mice
Tóth, M., & Wood, S. J. (2001) · Molecular Neurobiology · doi:10.1385/mn:23:2-3:101 · Cited by 45
“(85) – + Timpl et al.(84) – – = Contarino et al.”
McElroy, J., Ward, K., Zeller, K. L., Jones, K., Gilligan, P. J., He, L., & Lelas, S. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1239-3 · Cited by 45
“Knockout mice lacking the CRF1 receptors have reduced levels of anxiety in comparison with wild-type controls (Timpl et al. 1998).”
ResultNeuropeptides: implications for alcoholism
Cowen, M. S., Chen, F., & Lawrence, A. J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02394.x · Cited by 44
“These data seem to suggest that the CRF1 receptor is involved in adaptive responses to stress that are impaired in these mice, as well as the acute response to stressors (Timpl et al. 1998).”
BackgroundBiomarkers for Psychiatric Disorders
Turck, C. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-79251-4 · Cited by 44
Hinkle, R. T., Donnelly, E. T., Cody, D. B., Samuelsson, S. J., Lange, J. S., Bauer, M. B., Tarnopolsky, M. A., Sheldon, R. J., Coste, S. C., Tobar, E., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00081.2003 · Cited by 44
“mice (Charles River), CRF1R knockout mice (52), CRF2R”
BackgroundHypothalamic-Pituitary-Adrenocortical System and Mood Disorders: Highlights from Mutant Mice
Müller, M. B., Uhr, M., Holsboer, F., & Keck, M. E. (2004) · Neuroendocrinology · doi:10.1159/000076041 · Cited by 40
“Taken together, it was suggested that the CRH-OE mouse line provides a valid model for the endocrine and autonomic alterations associated with chronic stress or with human affective disorder. Unfortunately, analyses of anxiety-related behavior or pharmacological approaches using selective CRH receptor antagonists to r…”
BackgroundSelf-citationOh, J.-E., Chambwe, N., Klein, S., Gal, J., Andrews, S., Gleason, G., Shaknovich, R., Melnick, A., Campagne, F., & Toth, M. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.130 · Cited by 43
Hormonal pertubations in fibromyalgia syndrome
NEECK, G., & RIEDEL, W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07657.x · Cited by 43
Wang, T.-Y., Chen, X.-Q., Du, J.-Z., Xu, N., Wei, C., & Vale, W. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.023 · Cited by 43
Hinkle, R. T., Donnelly, E. T., Cody, D. B., Bauer, M. B., & Isfort, R. J. (2003) · Endocrinology · doi:10.1210/en.2003-0271 · Cited by 43
Wang, L. A., Hiller, H., Smith, J. A., de Kloet, A. D., & Krause, E. G. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00029.2016 · Cited by 43
2 Vagal control of gastrointestinal function
Grundy, D. (1988) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(88)90019-x · Cited by 43
Nicotine stimulates secretion of corticosterone via both CRH and AVP receptors
Lutfy, K., Aimiuwu, O., Mangubat, M., Shin, C., Nerio, N., Gomez, R., Liu, Y., & Friedman, T. C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07633.x · Cited by 42
“Mice deficient for CRH-R1 display a severe impairment of CRH- and stress-induced ACTH release from pituitary corticotropes, marked glucocorticoid deficiency, and reduced anxiety-like behaviors (Smith et al. 1998; Timpl et al. 1998; Muller et al. 2001).”
Oh, S. H., Park, C. O., Wu, W. H., Kim, J. Y., Jin, S., Byamba, D., Bae, B. G., Noh, S., Lim, B. J., Noh, J. Y., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.008 · Cited by 42
Endoplasmic reticulum stress contributes to CRH-induced hippocampal neuron apoptosis
Zhang, Y., Liu, W., Ma, C., Geng, J., Li, Y., Li, S., Yu, F., Zhang, X., & Cong, B. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.01.006 · Cited by 42
“and hormonal effects of CRH can be ascribed to CRHR1-mediated actions [23-25].”
BackgroundCallahan, L. B., Tschetter, K. E., & Ronan, P. J. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00195 · Cited by 42
Anisman, H., Prakash, P., Merali, Z., & Poulter, M. O. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.04.002 · Cited by 42
Nishikawa, H., Hata, T., Itoh, E., & Funakami, Y. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.352 · Cited by 42
Pharmacogenetic studies of alcohol self-administration and withdrawal
Crabbe, J. C., & Phillips, T. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1608-6 · Cited by 42
“Nonethanol-treated mice with a null mutation of the corticotropin hormone receptor 1 gene displayed less anxiety than wild type mice in the light/dark test; there was a suggestion of lesser susceptibility to ethanol withdrawalinduced anxiety in the null mutants (Timpl et al. 1998).”
BackgroundNeuropeptides and Anxiety-Related Behavior.
Landgraf, R. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.517 · Cited by 42
CRF-Deficient Mice Respond Like Wild-Type Mice to Hypophagic Stimuli
Swiergiel, A. H., & Dunn, A. J. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00065-9 · Cited by 42
White matter microstructure varies with post-traumatic stress severity following medical trauma
Harnett, N. G., Ference, E. W., Knight, A. J., & Knight, D. C. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9995-9 · Cited by 42
Markovic, D., Papadopoulou, N., Teli, T., Randeva, H. S., Levine, M. A., Hillhouse, E. W., & Grammatopoulos, D. K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107441 · Cited by 41
Kokras, N., Sotiropoulos, I., Pitychoutis, P. M., Almeida, O. F. X., & Papadopoulou‐Daifoti, Z. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.077 · Cited by 41
Greetfeld, M., Schmidt, M. V., Ganea, K., Sterlemann, V., Liebl, C., & Müller, M. B. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01865.x · Cited by 34
Zamora-Martinez, E. R., & Edwards, S. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00024 · Cited by 37
“…neurobiological basis for the negative reinforcement mechanisms important for the development and maintenance of alcoholism may include neuroadaptations in central neuropeptide systems associated with stress and anxiety, including the amygdala CRF system (Timpl et al., 1998; Shekhar et al., 2005).”
Shimosato, K., & Watanabe, S. (2003) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(03)00153-5 · Cited by 41
Ayala, A. R., Pushkas, J., Higley, J. D., Ronsaville, D. S., Gold, P. W., Chrousos, G. P., Pacák, K., Calis, K. A., Gerald, M. S., Lindell, S. G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032170 · Cited by 41
Harro, J., Tõnissaar, M., & Eller, M. M. (2001) · Neuropeptides · doi:10.1054/npep.2001.0851 · Cited by 41
Forster, G. L., Anderson, E. M., Scholl, J. L., Lukkes, J. L., & Watt, M. J. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.08.001 · Cited by 40
“…more often associated with stress responses and fear or anxiety-like behaviors in preclinical models (Heinrichs et al., 1997; Skutella et al., 1998; Timpl et al., 1998; Muller et al., 2003; Gehlert et al., 2005), there appears to be a more important role for CRF2 receptors specifically in the dRN…”
BackgroundAubry, J.-M. (2013) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2013.09.003 · Cited by 40
Stress and the CRH System, Norepinephrine, Depression, and Type 2 Diabetes
Perrelli, M., Goparaju, P., Postolache, T. T., del Bosque‐Plata, L., & Gragnoli, C. (2024) · Biomedicines · doi:10.3390/biomedicines12061187 · Cited by 40
“Crhr1 knockout mice show, in addition to a reduced stress response, reduced anxious behavior and increased exploratory activity [28,75].”
BackgroundMiguel, T. T., Gomes, K. S., & Nunes‐de‐Souza, R. L. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.05.003 · Cited by 40
“Present results are in line with previous findings showing an anxiolytic-like effect following the deletion of the CRF1 receptor gene in mice (Contarino et al., 1999; Smith et al., 1998; Timpl et al., 1998).”
Xu, H., Li, H., Liu, D., Wen, W., Xu, M., Frank, J. A., Chen, J., Zhu, H., Grahame, N. J., & Luo, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.614396 · Cited by 40
“CRF signaling may also be involved in anxiety behavior as CRF administration caused anxiety (Dunn and Berridge, 1990), whereas CRFR1 antagonists or knock-out of CRFR1 reduced anxiety-like behavior (Timpl et al., 1998; Zorrilla et al., 2002; Müller et al., 2003; Henckens et al., 2016).”
BackgroundCorticotropin-releasing factor-binding protein, stress and major depression
Eede, F. V. D., Broeckhoven, C. V., & Claes, S. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.02.002 · Cited by 40
Coste, S. C., Heard, A. D., Phillips, T. J., & Stenzel‐Poore, M. P. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00142.x · Cited by 39
“Compelling evidence supports a role for CRF1 in activating responses to stress and mediating the anxiogenic-like effects of CRF (Muller et al. 2003; Smith et al. 1998; Timpl et al. 1998).”
BackgroundZhu, H., Lee, M.-S., Agatsuma, S., & Hiroi, N. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm027 · Cited by 40
Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking
Schreiber, A. L., & Gilpin, N. W. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2017_86 · Cited by 40
“Canonically, CRFR1 has been considered to be “pro-stress,” because increases in CRFR1 signaling are anxiogenic (Dunn and Berridge 1990), whereas antagonizing or knocking out CRFR1 reduces anxiety-like behavior (Henckens et al. 2016; Muller et al. 2003; Timpl et al. 1998; Zorrilla et al. 2002).”
BackgroundGenetically engineered mice for studies of stress-related clinical conditions
Müller, M. B., & Keck, M. E. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00049-8 · Cited by 40
McDowell, E. N., Kisielewski, A. E., Pike, J. W., Franco, H. L., Yao, H. H., & Johnson, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047359 · Cited by 39
Russell, A. L., Handa, R. J., & Wu, T. J. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.09.014 · Cited by 39
CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping
Ingallinesi, M., Rouibi, K., Moine, C. L., Papaleo, F., & Contarino, A. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.119 · Cited by 39
New drug targets in the signaling pathways activated by antidepressants
Páez-Pereda, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.017 · Cited by 39
Linthorst, A. C. E. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_7 · Cited by 39
Challis, B., Luan, J., Keogh, J. M., Wareham, N. J., Farooqi, I. S., & O’Rahilly, S. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802564 · Cited by 39
The Role of Peptides in Treatment of Psychiatric Disorders
Holsboer, F. (2003) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6020-6_2 · Cited by 39
Self-citationKojima, T., Mochizuki, M., Takai, T., Hoashi, Y., Morimoto, S., Seto, M., Nakamura, M., Kobayashi, K., Sako, Y., Tanaka, M., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.01.020 · Cited by 38
Antidepressant Drug Discovery in the Postgenomic Era
Holsboer, F. (2001) · The World Journal of Biological Psychiatry · doi:10.3109/15622970109026805 · Cited by 38
Self-citationRosinger, Z. J., Jacobskind, J. S., Guzman, R. M. D., Justice, N. J., & Zuloaga, D. G. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.045 · Cited by 37
“…Albany, NY 12222, dzuloaga@albany.edu, Phone: 518-442-4361, FAX: 518-442-4867h. uthor M anuscript A uthor M anuscript A uthor M anuscript controlling depressive- and anxiety-related behaviors as well as the HPA axis (Britton et al., 1986; Deak et al., 1999; Muller et al., 2003; Timpl et al., 1998).”
BackgroundPsychiatric Disorders - Trends and Developments
(2011) · InTech eBooks · doi:10.5772/2330 · Cited by 35
Takahashi, Y., Hibi, S., Hoshino, Y., Kikuchi, K., Shin, K., Murata-Tai, K., Fujisawa, M., Ino, M., Shibata, H., & Yonaga, M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300259r · Cited by 36
Verleye, M., Heulard, I., & Gillardin, J. (2009) · Alcohol · doi:10.1016/j.alcohol.2009.02.003 · Cited by 36
“As shown by other authors, withdrawal from chronic ethanol caused changes in behavior in the way of exacerbation in aversive response in this test (Barnes et al., 1990; Costall et al., 1990; Timpl et al., 1998; Wallis et al., 1995).”
BackgroundSherrin, T., Todorovic, C., Zeyda, T., Tan, C. H., Hon, P. W. T., Zhu, Y. Z., & Spiess, J. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002121 · Cited by 35
Weiser, M. J., Goel, N., Sandau, U. S., Bale, T. L., & Handa, R. J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.07.013 · Cited by 35
“Furthermore, CRHR1KO animals exhibit reduced, whereas CRHR2KO animals display increased anxiety (Smith et al., 1998; Timpl et al., 1998; Bale et al., 2000; Kishimoto et al., 2000).”
BackgroundPastor, R., Reed, C. L., Burkhart‐Kasch, S., Li, N., Sharpe, A. L., Coste, S. C., Stenzel‐Poore, M. P., & Phillips, T. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2284-6 · Cited by 35
“Single gene mutant mice were generated using now standard gene inactivation methods (Smith et al. 1998; Timpl et al. 1998; Coste et al. 2000), and the double mutant was created by crossing the single gene mutants.”
Metadata
- Authors
- Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Helmholtz Munich (DE)
- Corresponding author
- Wurst, Wolfgang
- Venue
- Nature Genetics
- Published
- 1998-06
- Volume
- 19
- Issue
- 2
- Pages
- 162-166
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/520
- OpenAlex
- W1572525448
- Semantic Scholar
- 963e2500bc129b9bfedf1ae198ec17a73626fcdc
- Cited by
- 919
- References
- 32
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 6 · 2022: 14 · 2021: 16 · 2020: 9 · 2019: 20 · 2018: 23 · 2017: 20 · 2016: 27 · 2015: 24 · 2014: 31 · 2013: 27 · 2012: 47
- FWCI
- 22.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Site cant be reached (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- corticotropin-releasing hormone receptor 1, stress response, anxiety-like behavior, ACTH, corticosterone, alcohol withdrawal, exploratory activity, CRH receptor 2, adenylate cyclase
- MeSH terms
- CRF Receptor, Type 1, Adrenocorticotropic Hormone, Ethanol, Animals, Anxiety, Cells, Cultured, Corticosterone, Pituitary Gland, Stress, Physiological, Substance Withdrawal Syndrome, In Situ Hybridization, Receptors, Corticotropin-Releasing Hormone, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.